The Medicare GLP-1 Bridge $50 copay: how it works and which drugs it covers

The headline number is real — eligible Medicare beneficiaries pay a $50 copay for covered GLP-1 drugs under the Bridge. But three details behind that number surprise almost everyone: your deductible doesn’t apply, the copay never counts toward your out-of-pocket totals, and one popular drug is only covered in one specific pen. Here’s what CMS actually says.

Get your free diagnosis

What the $50 copay is

Under the Medicare GLP-1 Bridge, CMS says plainly: "Eligible beneficiaries will have a $50 copay." [v2-3]

Note what that sentence does not say: the CMS page does not attach a frequency to the $50 — it does not say "per fill," "per prescription," or any time period at all. [v2-3] You may see "$50 a month" repeated around the internet, but that wording is not on the CMS page — for how the copay applies to your fills, check the official CMS Bridge page or call 1-800-MEDICARE. [v2-12]

The Bridge runs between July 1, 2026 and December 31, 2027. [v2-1]

Three fine-print facts most coverage articles miss

All three come from the same CMS sentence, verbatim: "the Part D deductible will not apply, no part of the $50 copay counts towards the beneficiary's TrOOP costs, and there is no low-income subsidy (LIS) provided for LIS beneficiaries." [v2-3]

1. Your Part D deductible does not apply. You don't have to "meet your deductible" before the $50 copay kicks in — the deductible simply is not part of the Bridge. [v2-3]

2. The $50 does not count toward TrOOP. TrOOP ("true out-of-pocket costs") is the running total that moves you through the Part D benefit phases. No part of your Bridge copays counts toward it — so months of Bridge copays will not move you closer to the Part D out-of-pocket cap. [v2-3]

3. No Extra Help / LIS discount on the Bridge copay. If you get the low-income subsidy (Extra Help) on your regular Part D drugs, note that CMS says there is no LIS provided for LIS beneficiaries under the Bridge — the copay is $50 for eligible beneficiaries. [v2-3]

Why is the Bridge different from your normal drug benefit? Because it isn't run through your Part D plan's claims system at all: in 2026, CMS is using a single central processor to manage prior authorization, claims adjudication, and payment to pharmacies. [v2-4]

Which drugs — and which formulations — are covered

CMS's provider page defines an eligible GLP-1 drug as "any of the following products when used to reduce excess body weight and maintain weight reduction: Foundayo®, Wegovy® (injection and tablets), and Zepbound® (KwikPen®)." [v2-5]

The formulation detail matters more than it looks:

• Foundayo — all formulations. [v2-6]
• Wegovy — all formulations (injection and tablets). [v2-5] [v2-6]
• Zepbound — the KwikPen formulation only. CMS states: "The single-dose vial and single-dose pen formulations of Zepbound® will not be available." [v2-6]

If your current Zepbound prescription is for single-dose vials or single-dose pens, that exact prescription cannot be filled through the Bridge — talk to your prescriber about whether the KwikPen formulation works for you. [v2-6] CMS posts the specific covered NDC list on its provider page, and notes the drug list can be updated. [v2-6]

What the $50 copay does not tell you

The copay is only the last step. To actually use the Bridge you must be in an eligible Part D plan type, meet the published clinical criteria (attested by your prescriber in the prior authorization), and not have a diagnosis that routes the drug through Part D instead. Those rules have their own pages in this series:

• Eligibility self-check
• Already paying cash for a GLP-1
• Medicare Advantage / employer plans
• How to apply

This page summarizes public CMS guidance as of July 2026 and is general information, not medical or insurance advice. Program details — including the covered drug list and NDCs — are set by CMS and may change. Always confirm current rules on the official CMS Medicare GLP-1 Bridge page and at Medicare.gov/glp1bridge. [v2-12]